5HVF | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | BMA, FLC, MAN, NAG, ZN | enzyme |
| ||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Elucidation of the molecular mechanisms of two nanobodies that inhibit TAFI activation and TAFIa activity., Zhou X, Weeks SD, Ameloot P, Callewaert N, Strelkov SV, Declerck PJ, J Thromb Haemost. 2016 Jun 9. doi: 10.1111/jth.13381. PMID:27279497 |
Data retrieval |
![]() |
View 5HVF in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |